Bar-Lev Schleider, L., Mechoulam, R., Saban, N., Meiri, D., & Novack, V. (2022). Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo-controlled randomized clinical trial. Nature Medicine, 28(4), 814–825. https://doi.org/10.1038/s41591-022-01786-4
Broers, B., Patà, Z., Mina, A., Wampfler, J., de Saussure, C., & Pautex, S. (2019). Prescription of a THC/CBD-based medication to patients with dementia: A pilot study. Medical Cannabis and Cannabinoids, 2(2), 72–79.
Carroll, C. B., Bain, P. G., Teare, L., Liu, X., Joint, C., Wroath, C., & Zajicek, J. P. (2004). Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study. Neurology, 63(7), 1245–1250.
Chagas, M. H. N., Zuardi, A. W., Tumas, V., Pena-Pereira, M. A., Sobreira, E. T., Bergamaschi, M. M., Crippa, J. A. S. (2014). Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial. Journal of Psychopharmacology, 28(11), 1088–1098.
Gofrit, S. G., Barak, O., & Ben-Hur, T. (2020). Cannabinoid extract in microdoses ameliorates mnemonic Alzheimer’s disease symptoms: A case report. Journal of Alzheimer’s Disease Reports, 4(1), 51–59. https://doi.org/10.3233/ADR-200171
Goor, Y., Regev, K., & Offen, D. (2022). Cannabinoids in the management of frontotemporal dementia: A case series. Journal of Clinical Medicine, 11(8), 2143. https://doi.org/10.3390/jcm11082143
Herrmann, N., Ruthirakuhan, M., Gallagher, D., Verhoeff, N. P. L. G., Kiss, A., Black, S. E., & Lanctôt, K. L. (2019). Randomized placebo-controlled trial of nabilone for agitation in Alzheimer’s disease. American Journal of Geriatric Psychiatry, 27(11), 1161–1173.
Holden, S. K., Vanegas-Arroyave, N., & Leehey, M. A. (2022). Higher risk, higher reward? Self-reported effects of real-world cannabis use in Parkinson’s disease. Movement Disorders Clinical Practice, 9(3), 340–350. https://doi.org/10.1002/mdc3.13414
Kumar, U. (2024). Cannabinoids: Role in neurological diseases and psychiatric disorders. International Journal of Molecular Sciences, 26(1), 152.
Lotan, I., Treves, T. A., Roditi, Y., & Djaldetti, R. (2014). Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: An open-label observational study. Clinical Neuropharmacology, 37(2), 41–44.
Lazarini-Lopes, W., et al. (2023). Medical cannabis in the treatment of Parkinson’s disease: A retrospective chart review. Frontiers in Neurology, 14, 1142137. https://doi.org/10.3389/fneur.2023.1142137
Saft, C., von Hein, S. M., Lücke, T., Thiels, C., & Andrich, J. (2018). Cannabinoids for treatment of dystonia in Huntington’s disease. Journal of Huntington’s Disease, 7(2), 167–173.
Shelef, A., Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., & Baruch, Y. (2016). Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: An open-label, add-on, pilot study. Journal of Alzheimer’s Disease, 51(1), 15–19.
Sieradzan, K. A., Fox, S. H., Hill, M., Dick, J. P. R., Crossman, A. R., & Brotchie, J. M. (2001). Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: A pilot study. Neurology, 57(11), 2108–2111.
Tischler, H., Shiner, T., & Bar-Shira, A. (2021). Long-term safety of medical cannabis in Parkinson’s disease: A retrospective case-control study. Journal of Parkinson’s Disease, 11(3), 1235–1244. https://doi.org/10.3233/JPD-212743
Volicer, L., Stelly, M., Morris, J., McLaughlin, J., & Volicer, B. J. (1997). Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease. International Journal of Geriatric Psychiatry, 12(9), 913–919.
Woodward, M. R., Harper, D. G., Stolyar, A., Forester, B. P., & Ellison, J. M. (2014). Dronabinol for the treatment of agitation and aggression in Alzheimer’s disease. American Journal of Geriatric Psychiatry, 22(4), 415–417.
Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2009). Cannabidiol for the treatment of psychosis in Parkinson’s disease. Journal of Psychopharmacology, 23(8), 979–983.
